C92.9
Myeloid leukemia, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Myeloid leukemia, unspecified (ICD-10 code C92.9), is a type of blood cancer that originates in the bone marrow—the spongy tissue inside bones where blood cells are produced. In this condition, abnormal myeloid cells—an essential component of the blood—grow uncontrollably. These abnormal cells can interfere with the production of healthy blood cells, leading to various health complications. Because of its unspecified nature, this diagnosis covers different forms of myeloid leukemia that have not been precisely categorized, including acute or chronic types.
Causes & Symptoms
Clinical Causes: Genetic mutations in blood-forming cells Previous exposure to high doses of radiation or certain chemotherapy treatments Exposure to toxic chemicals such as benzene Family history of blood cancers Certain genetic disorders like Down syndrome
Key Symptoms: Feeling tired or weak Frequent or severe infections Easy bruising or bleeding Unusual paleness Bone pain or tenderness Frequent headaches or dizziness Enlarged spleen or liver Weight loss without trying Fever or night sweats
Diagnostic & Treatment
Diagnosis Path: Diagnosing myeloid leukemia involves multiple steps, including:
Treatment Protocols: While specific treatment plans are tailored to each patient, common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C92.9 a billable ICD-10 code?
Yes, C92.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.9?
Clinical documentation must specify the nature of Myeloid leukemia, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference